Global Markets for Enzymes in Industrial Applications
March 30, 2012
Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR ENZYMES IN INDUSTRIAL APPLICATIONS (BIO030G) from BCC Research (www.bccresearch.com), the global market for industrial enzymes was valued at $3.9 billion in 2011 and is expected to increase to nearly $6.1 billion in 2016, a five-year compound annual growth rate (CAGR) of 9.1%.
The industrial enzymes market can be broken down into three segments: technical enzymes, food and beverage enzymes, and others.
The technical enzymes segment accounted for nearly $1.2 billion in 2011 and is expected to increase at a CAGR of 8.2% to reach $1.7 billion in 2016.
The segment made up of food and beverage enzymes was valued at nearly $1.3 billion in 2011 and is expected to increase at a CAGR of 10.4% to reach $2.1 billion in 2016.
The segment made up of other enzymes was worth nearly $1.5 billion in 2011 and should be worth $2.2 billion in 2016, a CAGR of 8.7%.
Enzymes provide new and innovative biotechnological solutions, which in turn increase efficiency and productivity for manufacturers. Enzyme manufacturers utilize enzyme technology to develop and manufacture bulk and high-value-added products. By using enzymes as biocatalysts, manufacturers are able to develop new processes, which in turn yield new products in various markets.
Increased usage of enzymes is justifiable because they are natural and biodegradable. By using biodegradable enzymes as substitutes in the place of chemical-based products, manufacturing processes are being redeveloped into more environmentally-friendly processes, with less corrosive conditions. Compatibility of enzymes with the environment in addition to their ability to increase process efficiency and provide product specificity has enhanced the enzymes market globally.
This study contributes to the areas of market growth in food and beverages, animal feed, detergents, leather, and other technical enzyme manufacturers and users. Chemical, biochemical and biotechnical companies and industries, and research institutes will find this study to be of interest.
In addition to BIO030G, BCC also has published BIO091A, BIO092A, BIO093A, and BIO094A. These reports cover industrial enzymes with focuses, respectively, on the North American, European, and Asian regions, as well as emerging markets/rest of world.
Global Markets for Enzymes in Industrial Applications( BIO030G )
Publish Date: Mar 2012
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum